TECLens, Inc. is a company that develops a non-invasive, comfortable, and in-office vision correction procedure. Based in Connecticut, the firm has received equity funding to support its innovative medical treatments.
Subscribe to see TECLens’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
TECLens is a therapeutic devices company headquartered in Stamford, United States. Its most recent funding round, Series A2 Extension, raised $10M in August 2026. Xcout tracks 2 named people at TECLens, including Madhu Ayyagari (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
The 3 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A2 Extension | $10M | 1 named | |
| SEC Form D filing | $5.2M | — | |
| Series A | $9.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of TECLens's closest competitors — see the full list of competitors and alternatives →
Adaptilens, Inc. is an ophthalmic medical device company headquartered near Boston, Massachusetts, focused on developing advanced accommodating intraocular lenses (IOLs). Founded by ophthalmic device inventors, the company aims to restore natural range of vision for cataract patients through innovative lens technologies. It conducts clinical evaluations and secures venture backing to advance its medical device pipeline.
Lentechs is a clinical-stage ophthalmic medical device company that develops patented soft, suspended contact lenses designed for individuals with presbyopia. Its technology is engineered to be suspended behind the upper eyelid to allow free eye movement behind a rotationally-stable lens, providing vision correction at multiple distances.
AcuFocus, Inc. is a privately held ophthalmic medical device company headquartered in Irvine, California. The firm focuses on the development and commercialization of innovative technologies for treating various eye conditions.
Ocumetics Technology Corp. is an innovation-driven enterprise specializing in the development and production of diverse optical lenses. One of its key innovations is the Bionic Lens, an expandable intraocular lens crafted to be implanted within the eye's natural lens compartment, offering a solution that eliminates the need for external vision correction. The company maintains its corporate headquarters in Calgary, Canada.
Biorez, Inc. is a medical startup founded in 2008 and based in New Haven, Connecticut, focusing on advancing tendon and ligament healing. The company developed proprietary bio-inductive implant technology and received FDA 510(k) clearance for its products.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about TECLens? Suggest a correction · Work at TECLens? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.